Controversies in the Management of Stage 1 Non-Seminomatous Germ Cell Tumors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11934-013-0362-5.pdf
Reference24 articles.
1. Leibovitch L, Foster RS, Kopecky KK, et al. Improved accuracy of computerized tomography based clinical staging in low stage nonseminomatous germ cell cancer using size criteria of retroperitoneal lymph nodes. J Urol. 1995;154:1759–63.
2. •• Read G, Stenning SP, Cullen MH, Parkinson MC, Horwich A, Kaye SB, et al. Medical Research Council prospective study of surveillance for stage 1 testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol. 1992;10:1762–8. This study is a multivariate analysis analyzing risk factors for metastatic potential. Determining which patients are high risk is the central issue in the controversy over post-orchiectomy management.
3. Fung C, Kalish L, Brodsky G, Richie J, Garnick B. Stage I nonseminomatous germ cell testicular tumor: prediction of metastatic potential by primary histology. J Clin Oncol. 1988;6(9):1467–73.
4. Vergouwe Y, Steyerberg E, Eijkemans M, Albers P, Habbema J. Predictors of occult metastasis in clinical stage 1 non-seminoma: a systematic review. J Clin Oncol. 2003;22:4092–9.
5. Heidenreich A, Sesterhenn IA, Mostofi FK, et al. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastases. Cancer. 1998;83:1002–11.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Testicular Cancer Biomarkers: A Role for Precision Medicine in Testicular Cancer;Clinical Genitourinary Cancer;2019-02
2. Intermediate and long-term complications associated with adjuvant chemotherapy for stage I germ cell tumor patients;Current Opinion in Urology;2018-09
3. Management of Clinical Stage I Nonseminomatous Germ Cell Testicular Tumors: A 25-year Single-center Experience;Clinical Genitourinary Cancer;2017-12
4. Wann ist die operative Versorgung von Metastasen beim testikulären Keimzelltumor angezeigt und gibt es eine wissenschaftliche Grundlage dafür?;Der Urologe;2017-04-21
5. Indikationsstellung und Strategien: Hodenkarzinom;Die Urologie;2016
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3